Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
AAVogen
company
About
AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.
- 1 - 10
Details
- Last Funding Type
- Pre-seed
- Last Funding Money Raised
- $25K
- Industries
- Biotechnology,Health Care
- Founded date
- Aug 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases. This includes muscular dystrophy, inflammatory myopathies and cancer cachexia. We make you stronger.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$250K
AAVogen has raised a total of
$250K
in funding over 2 rounds. Their latest funding was raised on
Sep 1, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 1, 2019 | Grant | $225K | 1 | — | — | Detail |
| Aug 15, 2015 | Pre-seed | $25K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
AAVogen is funded by 2 investors.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
and Kilpatrick Townsend
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Grant |
Kilpatrick Townsend
|
— | Pre-seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
